Monday, May 16, 2022
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | News | Ibuprofen Safe Doesnt Raise Covid Death Risk Study

Ibuprofen safe, doesn’t raise Covid death risk: Study

By IANS
Published: Published Date - 06:35 PM, Sun - 9 May 21
Photo: IANS NSAIDs are common treatments for acute pain and rheumatological diseases such as rheumatoid arthritis and osteoarthrosis.

London: Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, is safe and does not lead to higher rates of death or severe disease in patients hospitalised with Covid-19, according to a new observational study of more than 72,000 people in the UK.

NSAIDs are common treatments for acute pain and rheumatological diseases such as rheumatoid arthritis and osteoarthrosis.

Early in the pandemic, there was debate on whether the use of such drugs increased the severity of Covid-19, which led to urgent calls for investigations between NSAIDs and Covid-19.

But, the study, led by ISARIC CCP-UK (International Severe Acute Respiratory and emerging Infection Consortium Clinical Characterisation Protocol United Kingdom), provides clear evidence that the continued use of NSAIDs in patients with Covid-19 is safe.

The findings are published in The Lancet Rheumatology journal.

Around a third of patients (30.4 per cent) who had taken NSAIDs prior to hospital admission for Covid-19 died, a rate which was similar (31.3 per cent) in patients who had not taken NSAIDs. In patients with rheumatological disease, the use of NSAIDs did not increase mortality.

Further, those who took NSAIDs were not more likely to be admitted to critical care, need invasive or non-invasive ventilation, or require oxygen, the researchers found.

“We now have clear evidence that NSAIDs are safe to use in patients with Covid-19, which should provide reassurance to both clinicians and patients that they can continue to be used in the same way as before the pandemic began,” said lead author Ewen Harrison, from the University of Edinburgh.

For the study, the team collected data on the medication patients had been prescribed, were currently taking, or had taken within 14 days prior to being admitted to hospital, as well as demographic information, and medical history. Of the 72,179 patients from England, Scotland, and Wales, 5.8 per cent (4,211) had taken NSAIDs prior to hospital admission between January and August 2020.

Further research and clinical trials are needed to establish whether NSAIDs are safe in different populations and whether their anti-inflammatory effects have any impact on patients with Covid-19, the researchers said.

  • Follow Us :
  • Tags
  • Covid-19
  • Death
  • disease
  • Ibuprofen

Related News

  • India records 2,202 new COVID-19 infections, 27 fatalities

  • Andhra woman village volunteer stabbed to death

  • JNTU-Hyderabad to revamp curriculum of all its courses

  • Ibuprofen, paracetamol in pregnancy ups preterm, stillbirth risks by 50 per cent: Study

  • Banks need a new playbook

  • India records 2,858 COVID-19 cases, 11 fatalities

Latest News

  • Vijay Deverakonda, Samantha slammed by Pawan Kalyan fans for ‘Kushi’ movie title

    7 mins ago
  • Look at Tier 2 cities too, KTR tells IT firms

    18 mins ago
  • CM KCR remembers Buddha

    52 mins ago
  • Minister Errabelli inaugurates free coaching for job aspirants in Palakurthy

    56 mins ago
  • Lingayat community seeks OBC status, BJP in a fix

    1 hour ago
  • Pics of Sai Pallavi watching movie in disguise go viral

    1 hour ago
  • Zee Telugu invites viewers to vote for their favourite eliminated contestant

    1 hour ago
  • Celebs set the temperatures soaring with super cool summer anthem

    2 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam